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Signal transduction through the RAS/mitogen-activated protein kinase (MAPK) pathway depends on a diverse collection of proteins regulating
positively and negatively signaling flow. We previously conducted a genetic screen in Drosophila to identify novel components of this signaling
pathway. Here, we present the identification and characterization of a new gene, alphabet (alph), whose activity negatively regulates RAS/MAPK-
dependent developmental processes in Drosophila and this, at a step downstream or in parallel to RAS. alph encodes a protein phosphatase 2C
(PP2C) family member closely related to the mammalian PP2C alpha and beta isoforms. Interestingly, although alph gene product does not appear
to be essential for viability, its elimination leads to weak but significant developmental defects reminiscent of an overactivated RAS/MAPK
pathway. Consistent with this interpretation, strong genetic interactions are observed between alph alleles and mutations in bona fide components
of the pathway. Together, this work identifies a PP2C of the alpha/beta subfamily as a novel negative regulator of the RAS/MAPK pathway and
suggests that these evolutionarily conserved enzymes play a similar role in other metazoans. Finally, despite the relatively large size of the PP2C
gene family in metazoans, this study represents only the second genetic characterization of a PP2C in these organisms.
© 2006 Elsevier Inc. All rights reserved.Keywords: Signal transduction; RAS; MAPK; PP2C; Phosphatase; Drosophila developmentIntroduction
The RAF/MEK/MAPK pathway is a pivotal route through
which the small GTPase RAS transmits proliferation, differen-
tiation, or survival signals elicited by membrane receptors (Katz
and McCormick, 1997). Upon activation, GTP-loaded RAS
physically associates with RAF thereby initiating a complex
series of events leading to RAF activation. This step triggers the
well-documented activating phosphorylation cascade from
RAF to MEK and from MEK to MAPK. Activated MAPK
then moves to the nucleus or to other cytoplasmic locations and
modulates by phosphorylation the activity of a large set of⁎ Corresponding author. Institute for Research in Immunology and Cancer,
Laboratory of Intracellular Signaling, Université de Montréal, C.P. 6128
Succursale Centre-Ville, Montréal, Québec, Canada H3C 3J7. Fax: +1 514 343
6843.
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doi:10.1016/j.ydbio.2006.02.046substrates that in turn will orchestrate a cell-specific response
(Pearson et al., 1999; Widmann et al., 1999).
In addition to the three basic kinases, a surprisingly large
number of regulatory components have been found to modulate
the pathway, and their characterization, although not complete, is
unveiling complex mechanisms shaping signaling flow (Chong
et al., 2003; Morrison and Davis, 2004; Kolch, 2005). Various
strategies have been devised to identify new components of the
RAS/MAPK pathway. For instance, one of these approaches
exploited Drosophila eye development as an assay to isolate
mutations in genes mediating or opposing RAS/MAPK signaling
(St Johnston, 2002). During eye development, cell fate
specification is governed by the reiterated use of EGFR-
stimulated RAS/MAPK signaling (Wolff and Ready, 1993;
Freeman, 1996). Therefore, up- or down-regulation of the
pathway during eye development, both by natural or artificial
means, alters cell differentiation and, as a consequence, often
leads to the visible roughening of the adult external eye surface.
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function or dominant-negative activity have been expressed in
the eye, and the resulting eye phenotypes were used in dominant
modifier screens (Dickson et al., 1996; Karim et al., 1996; Raabe
et al., 1996; Rebay et al., 2000; Smith et al., 2002; Therrien et al.,
2000). Although these screens identified several new positively
acting genes, significantly fewer negative regulators were
uncovered by this approach. Nonetheless, as expected for a
pathway that relies on phosphorylation events, two of the
genetically defined negative loci encoded phosphatases. One of
these, microtubule star (Mts), corresponds to the catalytic subunit
of protein phosphatase 2A (PP2A) and appears to negatively
regulate an event between RAS and RAF (Wassarman et al.,
1996). The second one, named Protein Tyrosine Phosphatase-
Enhancer of RAS (PTP-ER), was found to specifically inactivate
MAPK by dephosphorylating the tyrosine residue of the
activation loop TEY motif (Karim and Rubin, 1999). More
recently, genetic studies revealed that the Drosophila dual
specificity phosphatase MKP-3 also negatively regulates the
RAS/MAPK pathway during development (Kim et al., 2004).
We previously conducted a modifier screen based on a kinase
suppressor of Ras (KSR)-dependent rough eye phenotype to
identify novel components of the RAS/MAPK pathway
(Therrien et al., 2000). KSR is a RAF-related protein that is
thought to act as a scaffold of the MAPK module by bridging
RAF, MEK, and MAPK together (Morrison and Davis, 2004).
Expression of the isolated kinase domain of KSR during
Drosophila eye development inhibits photoreceptor cell differ-
entiation and produces a rough eye as it interferes with RAS-
mediated MAPK activation owing to its presumed ability to
sequester MEK (Therrien et al., 1996; Roy et al., 2002). We
predicted that loss-of-function mutations in positively acting
components should worsen the KSR dominant negative (KDN)
phenotype and thus should be recovered as Enhancers of KDN,
whereas loss-of-function mutations in genes encoding negative
regulators should fall within the Suppressors of KDN category.
Fifteen groups of enhancers were isolated, and the corresponding
genes have been identified for several of these, including known
positively acting loci such as egfr, Ras, andmapk (Therrien et al.,
2000). In contrast, only four groups of suppressors were isolated.
Here, we report the identification and characterization of one of
these groups called Suppressor of KDN 3-1 (SK3-1). The SK3-1
locus, renamed alphabet (alph), encodes a protein phosphatase
2C (PP2C) highly related to the mammalian PP2C alpha and beta
isoforms. alph activity appears to be dispensable for viability as
mutations that eliminate or severely reduce catalytic function are
homozygous viable. Nonetheless, homozygous mutant flies
have phenotypic defects reminiscent of a hyperactivated RAS/
MAPK pathway. In agreement with this interpretation, alph
alleles dominantly enhanced phenotypes caused by activated
components of the RAS/MAPK and genetically interacted with
mutations in bona fide components of the pathway, whereas
ectopic expression of the wild-type form had the opposite effect.
Finally, our genetic interaction data suggest that alph activity is
required downstream or in parallel to RAS. Together, these
findings identify a phosphatase of the PP2C family as a novel
negative regulator of RAS/MAPK signaling in Drosophila.Materials and methods
Genetics and fly stocks
Fly maintenance, genetic interaction studies and P[w+] mapping were
conducted according to standard procedures. The PBac{PB}CG1906c04528 and
EP lines were obtained from the Bloomington and Szeged stock centers,
respectively. The sE-alph and UAS-alph lines were generated by P-element-
mediated germline transformation as described previously (Rubin and
Spradling, 1982).
Homozygous mutant clones of alphS-331 were generated by the FRT
technique (Xu and Rubin, 1993) using the homologous FRT82B, Ubi-GFP
chromosome. Eye-specific clones were induced using the eyFlp1.2 transgene
(Therrien et al., 1998). UAS-RASV12 flies were described previously (Karim and
Rubin, 1998). RASV12- and RASV12/Alph-expressing clones were induced 72
h after egg deposition (AED) by a 10-min heat shock at 37°C. The y,w,hs-flp122;
Act>CD2>Gal4; UAS-GFP line was kindly provided by M. Miron and was
previously described in Neufeld et al. (1998).
Molecular analysis of alph alleles
Genomic DNA from each alph homozygous viable alleles (XS-88, S-331,
and S-355) was used to amplify by PCR the predicted exons of the alph locus
(Fig. 2A). The exons were then directly sequenced from the PCR products.
Mutations were confirmed by sequencing a second PCR product from a distinct
DNA sample.
Plasmids
alph cDNAs corresponding to the open reading frame (ORF) of transcripts
RA/C/D and RB (Fig. 2) were amplified by PCR from the LD cDNA library
(BDGP), cloned into the Not1 site of pBlueScript (BS) II (Stratagene) and
entirely sequenced. The third variant (RE) was generated by PCR using a 3′-
oligonucleotide encoding the C-terminal Alph-PE extremity (Fig. 2C). The three
alph cDNAs were inserted in the psE (Dickson et al., 1992) P-element vector.
The RB transcript was also introduced in the pUAST (Brand and Perrimon, 1993)
P-element vector.
The pBS-alph construct (transcript RA/C/D) was used as a template for
mutagenesis (QuickChange™; Stratagene) to generate the three mutations
identified in the screen (Fig. 2B) as well as a phosphatase-inactivating R189A
mutation. Wild-type and mutant versions were then moved into pGEX-4T3
(Amersham) to produce GST fusion proteins in BL21 cells (Novagen).
Alph antibodies and fly extracts
Rabbit polyclonal antibodies were raised (Sigma Genosys) against full-
length Alph fused to GST as described above. Crude anti-serum was directly
used in Western blots (1/2000) to detect endogenous Alph from either wild-type
or mutant fly protein extracts. The lysates were prepared by homogenizing
tissues or whole animals of the indicated stage in NP-40 lysis buffer (Therrien et
al., 1996). Anti-actin clone 4 (1/1000; Boehringer-Mannheim) was used to
monitor protein loadings.
Phosphatase assay
Phosphatase assays were conducted in 50 μl of solution A (50 mMTris–HCl
pH 7.0, 0.1% β-mercaptoethanol) supplemented with 60 mMMgOAc, 1 mg/ml
BSA and 1 μg 32P-casein. Reactions were initiated by adding GST-Alph proteins
(2.5 μg) and incubated at 30°C for 30 and 90 min. Reactions were stopped by
adding 20% trichloroacetic acid (TCA). Non-precipitable [32P] was determined
by scintillation counting. 32P-labeled phospho-casein was prepared according to
McGowan and Cohen (1988).
Histology
Scanning electron microscopy and sectioning of adult fly eyes were
performed as described by Wassarman et al. (2000) and Tomlinson and Ready
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glass slide.
Eye imaginal discs from third instar larvae or pupae (45h after pupal
formation) were dissected in plain Schneider medium (Invitrogen), fixed in PBS
1× + 4% paraformaldehyde for 15 min at room temperature and washed three
times with PBT (PBS 1× + 0.2% Triton X-100). Primary antibodies were
incubated in PBT + 2.5% fat-free dry milk overnight at 4°C with gentle rocking.
Primary antibodies and dilutions were mouse anti-Cut (1/1000; DSHB), rabbit
anti-Dlg (1/2000; Woods and Bryant, 1991), mouse anti-prospero (1/100,
DSHB), rabbit anti-BarH1 (1/200; Higashijima et al., 1992), rat anti-Elav (1/
1000; DSHB), mouse anti-dpMAPK (1/1000; Sigma). Samples were then
washed with PBT and incubated with appropriate species-specific Cy3-, Cy5-,
or FITC-conjugated secondary antibodies (1/1000; Jackson Immuno-Research
Laboratories) for 2h at room temperature in PBT + 2% BSA. Samples were
again washed with PBT + 2% BSA, then mounted in Vectashield (Vector
Laboratories) and analyzed by confocal microscopy.
In situ hybridization
Alph sense and antisense RNA probe (∼700 bp) preparation, embryo
fixation, post-fixation treatment, and hybridization were performed as
described in Parthasarathy et al. (in press; also available at http://www.
utoronto.ca/krause/). After hybridization, embryos were “electrowashed” at
100V for 30 min in wells of a 2% agarose gel (TAE 1×). They were then
washed for 10 min in PBT (1× PBS, 0.1% Tween-20) and blocked with 20%
heat-inactivated FBS in PBT for 1h. Embryos were then incubated with anti-
digoxigenin (Roche; 1/750) in 20% heat-inactivated FBS for 1h and
subsequently washed for 1h in PBT. Detection was done using the NBT/
BCIP solution from Roche as described by the manufacturer.Results
SK3-1 alleles enhance RAS/MAPK signaling during eye
development
The SK3-1 complementation group comprises four alleles
(Therrien et al., 2000). The ability of an allele (S-355) to
dominantly suppress the KDN rough eye phenotype is shown in
Fig. 1 (compare B and C). To confirm that the suppression
reflected an augmented number of photoreceptor cells, we
sectioned adult fly retinas and counted the number of ommatidia
missing the R7 photoreceptor cell. In a KDN/+ genetic
background, 70% of the ommatidia were missing the R7 cell,
whereas this number was reduced to 20% in a KDN/SK3-1S-355
background (Table 1). Similar results were found with a second
allele (S-331; Table 1). This effect was not specific to the R7
cells as the alleles also suppressed the loss of outer
photoreceptors caused by KDN (data not shown). Together,
these results suggested that the SK3-1 locus encodes a protein
that negatively regulates photoreceptor cell differentiation.
Given that photoreceptor cell differentiation depends on
RAS/MAPK signaling, it is possible that the SK3-1 alleles
specifically increased signaling through this pathway. Consis-
tent with this possibility, the alleles enhanced the rough eye
phenotype caused by expression of a gain-of-function of RAS
(RASV12; Fig. 1, compare D and E, and Therrien et al., 2000).
The enhancement was not restricted to RASV12 as similar rough
eye phenotypes produced by either an activated Sevenless
receptor (SEVS11; Basler et al., 1991), activated RAF
(Tor4021RAF; Dickson et al., 1992), or activated MAPK
(Sevenmaker [Sem]; Brunner et al., 1994) were also augmentedby the alleles (Fig. 1, compare F and G; and data not shown).
Furthermore, tangential adult eye sections confirmed the ability
of the SK3-1 alleles to increase the number of extra R7 cells
produced by the MAPKSEM transgene (Table 1 and data not
shown).
Given that the effect of RASV12 expressed in the eye does
not appear to be modifiable by mutations in upstream
components (Karim et al., 1996 and unpublished observation),
it suggests that SK3-1 activity is acting downstream or in
parallel to RAS. However, similar conclusions could not be
made with Tor4021RAF or MAPKSEM as these activated
variants still appear to be influenced by upstream events
(Oellers and Hafen, 1996; Wassarman et al., 1996). We also
tested the position of alph activity with respect to a
transcriptional target of the RAS/MAPK pathway known as
phyllopod (phyl; Chang et al., 1995; Dickson et al., 1995). Like
activated signaling components of the RAS/MAPK pathway,
overexpression of Phyl during eye development is sufficient to
drive the R7 cell differentiation program in non-neuronal cells
(Chang et al., 1995). Interestingly, unlike the other activated
components, the SK3-1 alleles did not enhance the rough eye or
the number of additional R7 cells produced by Phyl over-
expression (Fig. 1, compare H and I, and Table 1). Taken
together, these findings suggest that SK3-1 activity is required at
a step downstream or in parallel to RAS, but upstream of Phyl.
The SK3-1 locus encodes a homologue of the mammalian
Protein Phosphatase 2C α and β isoforms
The four SK3-1 alleles had been previously mapped
meiotically to 3–100 on the third chromosome (Therrien et al.,
2000). Two of the alleles (SK3-1XS-88, SK3-1S-331) are homozy-
gous viable, whereas the other two (SK3-1S-292, SK3-1S-355)
were originally identified as recessive lethal alleles. However,
outcrosses of the SK3-1S-355 allele separated the SK locus from a
secondary, but non-relevant recessive lethal mutation shared
with the SK3-1S-292 allele (data not shown). Like SK3-1XS-88and
SK3-1S-331, the outcrossed SK3-1S-355 allele is homozygous
viable. Similarly, the SK locus presents in the SK3-1S-292 line is
probably also homozygous viable as this line is viable when
tested in complementation assays with the other three viable
alleles.
To precisely position the SK3-1 locus, we further mapped the
ability of SK3-1S-355 to suppress the KDN rough eye phenotype
with respect to P[w+]-element lines of the EP collection inserted
in the area (Rorth, 1996). This high-resolution mapping
technique allowed us to place the SK3-1 locus exactly at
equal distance between the insertion sites of EP(3)3522 and EP
(3)1005 located at cytological position 99A7 and 99C4,
respectively (data not shown). Using the FlyBase Genome
Browser tool (http://www.flybase.bio.indiana.edu), the P-ele-
ments were found to be separated by ∼550 kb of genomic
DNA. In the middle of this interval, five candidate genes
(CG1906, CG7567, CG7568, CG11470, and CG31041)
spanning a 50-kb stretch are predicted to lie (data not
shown). One of these, CG1906, encodes a serine/threonine
(Ser/Thr) phosphatase of the PP2C family. As the RAS/
Fig. 1. SK3-1modulates RAS/MAPK rough eye phenotypes. Scanning electron micrographs of adult eyes of the following genotypes: (A) WT. (B) P[sE-KDN]/+. (C)
P[sE-KDN]/+; SK3-1S-355/+. (D) P[sev-RASV12]/+. (E) P[sev-RASV12]/+; SK3-1S-355/+. (F) sev-Sem/+. (G) sev-Sem/SK3-1S-355. (H) sev-phyl/+. (I) sev-phyl/SK3-1S-355.
Anterior is to the right.
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suspected that it might be the relevant gene. To test this
possibility, we isolated genomic DNA for each of the three
viable alleles and sequenced the predicted exons of CG1906
(Fig. 2A). In agreement with our hypothesis, all three alleles
were found to have a single point mutation affecting a highly
conserved residue within the catalytic domain (Figs. 2B and
C), thereby providing compelling evidence that the SK3-1
locus corresponds to CG1906. In support for this conclusion,
eye-specific expression of a CG1906 cDNA fully rescued theability of SK3-1 alleles to dominantly modify the KDN or
RASV12 rough eye phenotypes (data not shown).
Five splicing variants are predicted to originate from the
CG1906 locus (Fig. 2A). These transcripts should give rise to
three protein variants distinguishable by their unique C-terminal
extremity (Fig. 2C). Amino acid sequence comparison to PP2C
family members from other species identified mammalian PP2C
alpha and beta isoforms as the closest homologues (∼53% of
amino acid identity; Fig. 2B, Supplemental Fig. S1). Based on
this similarity, the locus was renamed alphabet (alph). Alph
Table 1
SK3-1 genetic interaction studies
Genotype Mean number of R7
cells/ommatidium
WT 1
sE-KDN/+ 0.30 ± 0.015 (n = 892)
sE-KDN/+; SK3-1S-331/+ 0.76 ± 0.015 (n = 774)
sE-KDN/+; SK3-1S-355/+ 0.80 ± 0.016 (n = 640)
sev-Sem/+ 2.55 ± 0.034 (n = 811)
sev-Sem/+; SK3-1S-331/+ 2.75 ± 0.037 (n = 538)
sev-Sem/+; SK3-1S-355/+ 3.39 ± 0.049 (n = 412)
sev-phyl/+ 1.71 ± 0.038 (n = 550)
sev-phyl/+; SK3-1S-331/+ 1.72 ± 0.047 (n = 504)
sev-phyl/+; SK3-1S-355/+ 1.70 ± 0.038 (n = 612)
SK3-1S-331 1.04 ± 0.011 (n = 406)
PBac{PB}CG1906c04528 1.03 ± 0.012 (n = 344)
yanP 1.37 ± 0.029 (n = 411)
yanP; SK3-1S-331/+ 1.86 ± 0.030 (n = 804)
yanP/+; SK3-1S-331 1.14 ± 0.021 (n = 477)
yanP; SK3-1S-331 2.88 ± 0.069 (n = 288)
yanP; PBac{PB}CG1906c04528 2.70 ± 0.055 (n = 349)
PTP-ERXE-3022/XE-2776 1.05 ± 0.009 (n = 733)
PTP-ERXE-3022/+; SK3-1S-331 1.08 ± 0.014 (n = 371)
PTP-ERXE-3022/XE-2776; SK3-1S-331/+ 1.43 ± 0.029 (n = 538)
PTP-ERXE-3022/XE-2776; SK3-1S-331 1.91 ± 0.043 (n = 414)
Adult eyes of the indicated genotypes were sectioned, and the mean number of
R7 photoreceptor cells ± SEM was determined from at least three eyes of
independent flies per genotype. The number (n) of ommatidia analyzed is also
indicated.
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genesis (Fig. 3A). Furthermore, Alph proteins could be detected
at various stages of fly development as well as in eye-antennal
and wing imaginal discs (Fig. 3B). Although specific splicing
variant expression remains to be determined, these results
suggest that Alph activity is ubiquitously present in Drosophila.
During the course of this work, a PiggyBac transposon
element (PBac{PB}CG1906c04528) inserted ∼100 bp upstream
of the first exon of the CG1906-RA, -RB and -RE transcripts
(Fig. 2A) has been made available by Exelixis™ (Thibault et
al., 2004). In contrast to the SK3-1 mutations, this insertion
eliminates Alph expression (Figs. 3B and C) and thus possibly
corresponds to a null mutation. Furthermore, this line is
homozygous viable and is also viable over our four alleles or
over a chromosomal deletion of the region (data not shown).
Therefore, these data strongly suggest that the alph gene is not
essential for viability. However, as slight eye and wing
developmental defects are observed in homozygous alph alleles
(see below), it indicates that Alph activity is important for the
development of at least these two tissues.
Alph is a catalytically active phosphatase
Before characterizing further the role of Alph with respect to
the RAS/MAPK pathway, we verified whether it is catalytically
active and, if so, examined the effect that the mutations
recovered in the screen have on catalytic activity. To accomplish
this, we separately fused to GST the wild-type (WT) and the
three mutant versions of Alph encoded by the XS-88, S-331, and
S-355 alleles and evaluated their respective phosphataseactivity. We also generated a phosphatase-dead control
(R189A) based on a similar mutation previously shown to
inactivate catalytic function of other PP2Cs (Chin-Sang and
Spence, 1996; Takekawa et al., 1998). The GST fusion proteins
were purified from bacterial lysates (Fig. 4A) and assayed using
32P-labeled phospho-casein as a substrate. As shown in Fig. 4B,
the wild-type protein displayed phosphatase activity while, as
expected, the R189A variant was inert. Interestingly, all three
mutations recovered in the screen had an impaired catalytic
function and among which the G120E mutant derived from the
S-331 allele was found to be devoid of activity (Fig. 4B).
Together, these results demonstrated that Alph is an active
phosphatase, and that the alleles recovered in the KDN screen
are loss-of-function mutations.
Alph negatively regulates cell fate specification during eye
development
We were intrigued by the fact that the alleles recovered in
the screen dominantly modified the KDN or RASV12 rough
phenotypes and yet the homozygotes displayed no externally
visible phenotype in their eyes (not shown). One explanation
for this observation could be that Alph activity is redundant
with other proteins, and that RAS-mediated events are only
mildly altered in its absence in a wild-type background,
whereas in dosage-sensitive conditions, such as in KDN- or
RASV12-expressing developing eyes, slight variations in
signaling flow become perceptible. Nonetheless, we verified
whether mild internal defects reminiscent of an up-regulated
RAS/MAPK pathway could be detected in the homozygous
lines. We sectioned adult eyes of alphS-331 homozygotes and
looked for the presence of additional R7-like photoreceptor
cells, which is a classical hallmark of an overactivated RAS/
MAPK pathway (Zipursky and Rubin, 1994). As reported in
Table 1, the alphS-331 allele indeed exhibited a low (4%) but
significant number of extra R7 cells (for example, see Fig. 5D).
Similar findings were made with the other alleles, including the
PBac{PB}CG1906c04528 transposon line (Table 1 and data not
shown). Moreover, defects were not restricted to photoreceptor
cells as staining of pupal eye discs with a cone cell marker (α-
Cut) showed additional or missing cone cells in approximately
5% of the alphS-331 ommatidia (Fig. 5, compare B and E).
Mispositioned primary pigment cells (α-Bar; Fig. 5, compare C
and F) as well as additional secondary and tertiary pigment
cells (α-Dlg; Fig. 5 compare B and E) were also observed.
Therefore, the differentiation of extra eye-specific cells in the
alph mutant eyes is consistent with an up-regulation of the
RAS/MAPK pathway. Finally, given that ectopic activation of
the pathway in cone cell precursors has been shown to lead to
their transformation into supernumerary R7-like cells
(Zipursky and Rubin, 1994), we investigated whether such
an event might be occurring in the alph mutant eyes. Using
antibodies to concomitantly reveal cone cell outlines (α-Dlg)
and R7 cell-like nuclei (α-prospero; Kauffmann et al., 1996),
we analyzed 231 abnormally constructed ommatidia (addition-
al, missing or mispositioned cone cells) from pupal eye discs of
the alphS-331 genotype. Strikingly, approximately three out of
Fig. 2. Molecular analysis of the alphabet gene. (A) The genomic organization of five predicted alternative transcripts (RA to RE; FlyBase) transcribed from the
CG1906/alph locus is shown with green arrowheads and red stars representing the position of Start and Stop codons, respectively. (B) Amino acid sequence
comparison of Alph and its closest Drosophila homologue, the CG6036 gene product, to mouse PP2Cβ-1 (NCBI accession no. AAF56905) and S. cerevisiae Ptc3
(NCBI accession no. P34221). Amino acid changes of alphmutant alleles are indicated on top of the sequence and a putative coiled-coil motif found in Alph (aa 291–
311) is highlighted in blue. (C) Schematic representation of the predicted Alphabet protein variants (aa ∼370 in length depending on their C-terminal tail [PA/C/D, PB
and PE; FlyBase]) depicting the relative position of the catalytic domain (PP2Cc; aa 13–282), the mutations found in alph alleles and the putative coiled-coil (CC)
motif.
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had an extra R7-like cell (Fig. 5G), thereby strongly suggesting
that cone cell to R7 cell transformation is indeed taking place
in alph mutant eyes.
alph genetically interacts with other components of the RAS/
MAPK pathway
Although mild, the defects observed in alph mutant eyes
provided compelling evidence that the encoded phosphatase
plays a negative role on the RAS/MAPK pathway. To verify this
hypothesis further, we tested if alph could genetically interact
with bona fide negative regulators of the pathway such as yan,
which encodes an ETS domain-containing transcriptional
repressor (Lai and Rubin, 1992) and PTP-ER (Karim and
Rubin, 1999). As predicted, we found that one copy of thealphS-331 allele enhanced from 37% to 86% the number of extra
R7 cells observed in a homozygous viable hypomorphic allele
of yan (yanP; Table 1). Strikingly, when tested as a double
homozygote, 100% of the ommatidia had extra R7 cells with a
mean number of close to three R7 cells per ommatidium (Table
1), which visibly increased eye roughness (Fig. 6; compare A
and B). Similar results were obtained using the PBac{PB}
CG1906c04528 allele (Fig. 6C and Table 1).
Analogous analyses were conducted with PTP-ER. Like
alph, homozygous or trans-heterozygous PTP-ER alleles have a
mild effect on cell fate specification in the eye (Karim and
Rubin, 1999; Table 1). Remarkably, when tested as double
homozygotes, PTP-ERXE-3022 displayed a complete synthetic
lethality with alphS-331 (data not shown). Moreover, using a
PTP-ER trans-heterozygous configuration (XE-3022/XE-2776)
that did not show synthetic lethality when placed in an alphS-331
Fig. 3. alph expression during Drosophila development. (A) In situ hybridization of digoxigenin-labeled alph antisense RNA probe to wild-type embryos. Anterior is
to the left and dorsal is up. Alph transcripts are detected at all stages (1–17) of embryogenesis and are widely distributed. The expression patterns are consistent with
the high expression levels detected for CG1906 transcripts throughout embryogenesis by array profiling (Tomancak et al., 2002). Hybridization with a sense probe
gave no specific signal (not shown). (B) Proteins lysates from the indicated sources (10 μg) and derived from wild-type (WT) or mutant (PBac{PB}CG1906c04528)
genotypes were analyzed by Western blot using α-Alph polyclonal antibodies. Actin levels were monitored to control for equal protein loading. (C) Total adult fly
extracts (30 μg) prepared from wild-type (WT) or the other indicated homozygous genotypes were analyzed as in panel B. The reduced level and mobility shift
observed for the AlphS-331 protein are reproducible, but its significance is unknown.
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cells was nonetheless observed compared to the respective
single homozygotes (Table 1 and Figs. 6D and E).
Genetic interactions were also observed with general
components of the pathway, and these interactions were not
restricted to the eye. For example, a heterozygous Gap1 allele
(Gap1A13/+) introduced in the alphS-331 background not onlyincreased the number of extra R7 cell (data not shown) but
also induced the formation of additional wing vein material
(Fig. 6F). As wing vein development in Drosophila is
governed by EGFR-elicited RAS/MAPK signaling (Schweit-
zer and Shilo, 1997), it suggests that Alph negatively
regulates this process as well. Finally, another significant
example was the finding that alph alleles suppressed the
Fig. 4. alph encodes a catalytically active phosphatase. (A) GST-Alph fusion
protein variants were expressed and purified from E. coli lysates. Integrity and
quantity of the GST protein preparations were assessed by loading 5 μg of
proteins per sample on a 10% SDS-PAGE. Proteins were revealed by Coomassie
staining. (B) Relative phosphatase activity is determined as the ratio of 32P
released over the total input of 32P-casein in the presence of 2.5 μg of the
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et al., 2000).
Forced expression of Alph during eye development antagonizes
RAS/MAPK signaling
To complement the genetic interactions presented above, we
verified whether RAS/MAPK-dependent events could be
specifically altered by overexpressing Alph during eye
development. To this end, we separately introduced the three
spliced variants of alph downstream of the sE expression
cassette in a P-element vector to drive transgene expression in a
subset of differentiating cells in the eye, including cone cell and
R7 cell precursors (Basler et al., 1991). Surprisingly, although
several transgenic lines were obtained, none of these displayed
external or internal eye defects (data not shown and Table 2).
This apparent lack of activity might be due to the fact that
endogenous levels of Alph are not limiting. Therefore, forced
expression of Alph in a wild-type background might either not
affect or negligibly reduce RAS/MAPK signaling. Given that
expression of activated or dominant-negative components of the
RAS/MAPK pathway sensitizes the pathway to the point that
slight variations in signaling efficiency become detectable, we
tested whether the expression of alph transgenes in such
contexts would reveal their activity. Consistent with thishypothesis, overexpression of any of the three alph splicing
variants enhanced eye roughness as well as the loss of R7 cells
observed in the sE-KDN flies (Fig. 7, compare A and B; Table 2;
and data not shown). Conversely, alph expression suppressed
SEVS11 (data not shown), RASV12 (Fig. 7, compare C and D),
Tor4021RAF (data not shown), or MAPKSEM (Fig. 7, compare E
and F) rough eye phenotypes as well as it reduced the number of
additional R7 cells produced by MAPKSEM (Table 2 and
compare Figs. 7E′ and F′). In agreement with its role upstream
of phyl, alph expression did not suppress the rough eye
produced by phyl expression (Fig. 7, compare G and H) nor did
it decrease the mean number of extra R7 cells present in those
eyes (Table 2 and compare Figs. 7G′ and H′). Moreover, the
effect of alph expression was not restricted to phenotypes
produced by overexpression as it also efficiently suppressed the
rough eye phenotype and the extra R7 cells generated in a yanP
homozygous mutant background (Table 2 and data not shown).
Alph overexpression blocks RAS-induced MAPK activation
The genetic tools that have been used to functionally link
Alph to the RAS/MAPK pathway could not unambiguously
determine whether it is acting upstream or downstream of
MAPK. To address this point, we probed wild-type and alphS-
331 third instar eye-antennal discs with an anti-phospho-MAPK
antibody specific for the di-phosphorylated form of MAPK
(dpMAPK; Gabay et al., 1997) and compared the respective
levels of endogenously activated MAPK. If Alph was genuinely
acting upstream of MAPK, elimination of its activity should
specifically augment endogenous dpMAPK levels. We con-
ducted multiple staining experiments but failed to detect any
significant difference between wild-type and alphS-331 geno-
types (data not shown). We repeated those experiments in eye
discs containing alphS-331 homozygous mutant clones adjacent
to wild-type tissue to see if slight elevation of dpMAPK levels
could then be detected, but again, no significant variation was
observed (Fig. 8A). Although these negative results would
imply that Alph is acting downstream or in parallel to MAPK,
they are probably inconclusive given the weak eye phenotype
associated with the homozygous mutant alleles (Fig. 5). Indeed,
it is possible that a slight elevation of dpMAPK levels
undetectable by immunofluorescence is responsible for the
observed phenotype. Alternatively, it is possible that Alph is
acting on MAPK itself, and thus, as the anti-dpMAPK antibody
is specifically recognizing the dually phosphorylated form of
MAPK on the TEY motif, a specific increase of the threonine's
phosphorylated state would be undetectable.
We addressed the question differently and ask whether the
ability of Alph ectopic expression to suppress the RASV12
rough eye phenotype could be correlated with a reduction in
RAS-induced dpMAPK levels. To accomplish this, we
generated random clones of cells expressing RASV12 during
eye development using the Gal4-dependent “flip-out” technique
(Struhl and Basler, 1993) and evaluated the ability of Alph co-
expression to suppress dpMAPK production. As shown in Fig.
8, high levels of dpMAPK associated with RASV12-expressing
clones (panels B and B′) were dramatically reduced upon Alph
Fig. 5. alph homozygous mutant ommatidia have abnormal numbers of differentiated cells. Upper panels (A, B, C) correspond to WT, while lower panels (D, E, F)
correspond to alphS-331 homozygous eye tissues. (A, D) Tangential sections of adult eyes at the R7 photoreceptor cell level. The arrow in panel D points to an
ommatidium containing an additional R7 cell (the smaller size and the central location of the rhabdomere is characteristic of this class of photoreceptors). (B, E)
immunofluorescence stainings of 45 h pupal eye discs using α-Cut (reveals cone cell nuclei) and α-Dlg (reveals the outlines of secondary [2°] and tertiary [3°] pigment
cells as well as bristle cells [BC]). A normal ommatidium contains four Cut-positive cells surrounded by twelve additional accessory cells (six 2° and three 3° pigment
cells and three bristle cells) distributed in a stereotypical manner (Wolff and Ready, 1993). alphS-331 mutant eyes have ommatidia with missing or additional cone cells
(arrows). They also display additional pigment cells (yellow dots) or mispositioned 3° pigment and bristle cells. (C, F) Immunofluorescence stainings of 45-h pupal eye
discs using α-BarH1 (primary pigment cell marker) and α-Elav (neuronal marker) to highlight mispositioned (arrows) primary pigment cells in alphS-331 mutant eyes.
(G) Histogram showing the distribution of defects associated with 231 abnormally constructed ommatidia with respect to cone cell/R7 cell differentiation. The data
have been obtained by staining 45-h pupal eye discs with α-Dlg (at a focal plane revealing cone cell outlines) and α-Pros (to reveal cells engaged towards the R7 cell
fate).
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using an activated RAF construct (data not shown). Although
these results do not prove that Alph is acting upstream of
MAPK, they support this view.
Discussion
In this paper, we identified and characterized a new gene
encoding a Ser/Thr phosphatase of the PP2C family, named
alph, which appears to oppose RTK-driven RAS/MAPKsignaling during Drosophila development at a step downstream
or in parallel to RAS. Its ability to antagonize EGFR and
Sevenless activity suggests that its inhibitory effect is not
restricted to a single RTK. As its substrate(s) is/are currently
unknown, it remains unclear whether Alph activity is required
after signal transmission to down-regulate specific components
of the pathway or whether it is involved in maintaining
background signaling levels prior to activation. Alternatively, it
might be acting in a parallel pathway that in turn influences
RAS/MAPK signaling.
Fig. 6. alph alleles genetically interact with bona fide negative regulators of the RAS/MAPK pathway. Scanning electron micrographs of adult eyes of the following
genotype: (A) yanP homozygote (B) yanP; alphS-331 double homozygotes (C) yanP; alphPBac{PB}CG1906c04528 double homozygotes. (D) PTP-ERXE-3022/PTP-ERXE-2776.
(E) PTP-ERXE-3022/PTP-ERXE-2776; alphS-331 double homozygotes. The mean number of R7 cells per ommatidium is shown at the bottom of each micrograph. (F)
Micrograph of an adult wing homozygous for alphS-331 and heterozygous for Gap1A13. The arrowhead points to a typical location (distal end of the L2 vein) where
additional wing vein material is occurring in this genotype. In contrast to Gap1A13 heterozygotes which do not have any wing vein defects, alphS-331 homozygotes
show a low penetrance of wings with extra vein material (∼1%) appearing at the indicated location. Strikingly, this number rose to ∼50% when a Gap1A13
heterozygous allele is introduced in an alphS-331 homozygous background.
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pathway depends on multiple Ser/Thr phosphorylation events, it
is surprising that only two genes (mts and alph) encoding Ser/
Thr phosphatases have thus far been identified through modifier
screens in Drosophila (Wassarman et al., 1996; this study).
Although it is possible that very few phosphatases are involved
in reversing activating phosphorylation events, this situation
might in fact be due to functional redundancy among particular
Ser/Thr phosphatases. This could also explain why alph activity
is dispensable for viability, and that homozygous mutant flies
exhibit relatively weak phenotypes. Functional redundancy has
indeed been observed among homologous PP2C phosphatases
in yeasts (Young et al., 2002; Leroy et al., 2003). Although not
mutually exclusive, high gene dosage might also explain thefailure to identify phosphatases throughmodifier screens asmost
heterozygous mutations recovered in such screens (null and
hypomorphic alleles) might not be strong enough to alter rough
eye phenotypes. In this regard, it is interesting to note that the
PBac{PB}CG1906c04528 line, which probably corresponds to a
null mutation (Fig. 3), modified KDN and RASV12 accordingly
when tested as a heterozygote, but its effect was significantly
weaker than the alleles recovered in the screen (data not shown).
Nonetheless, when tested as a homozygote, it completely
suppressed KDN and very strongly enhanced RASV12 (data
not shown). These observations suggest that the alleles isolated
in the screen have some dominant negative activity.
Based on amino acid sequences and crystallographic studies,
Ser/Thr phosphatases have been categorized into two families:
Table 2
sE-alph genetic interaction studies
Genotype Mean number of R7
cells/ommatidium
sE-KDN/+ 0.30 ± 0.015 (n = 892)
sE-KDN/+; sE-alph/+ 0.00 ± 0.000 (n = 482)
sev-Sem/+ 2.55 ± 0.034 (n = 811)
sev-Sem/sE-alph 1.48 ± 0.031 (n = 546)
sev-phyl/+ 1.71 ± 0.038 (n = 550)
sev-phyl/sE-alph 1.70 ± 0.034 (n = 622)
yanP 1.37 ± 0.029 (n = 411)
yanP; sE-alph/+ 1.05 ± 0.012 (n = 283)
yanP; sE-alph 1.00 ± 0.003 (n = 359)
sE-alph 1.00 ± 0.000 (n = 348)
Adult eyes of the indicated genotypes were sectioned and the mean number of
R7 photoreceptor cells ± SEM was determined from at least three eyes of
independent flies per genotype. The data were obtained using a sE-alph line
(#3; 3rd chromosome insertion) expressing the alph-RB transcript.
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subfamilies, and the PPM family, which comprises the PP2C and
the pyruvate dehydrogenase phosphatase (PDPs) subfamilies
(Das et al., 1996). Functional studies conducted in yeasts, plants,
and mammalian cell lines have linked PP2Cs to a wide range of
intracellular functions, including signal transduction, cell cycle
progression, DNA damage checkpoint, and RNA splicingFig. 7. Overexpression of wild-type Alph modulates RAS/MAPK-dependent eye phen
(A) P[sE-KDN]/+. (B) P[sE-KDN]/+; P[sE-alph]/+. (C) P[sev-RASV12]/+. (D) P[se
P[sev-phyl]/+. (H) P[sev-phyl]/P[sE-alph]. Anterior is to the right. (E' to H') Apical ad
were observed with multiple independent lines expressing the same transcript as we(Schweighofer et al., 2004). Their involvement is probably
even wider as most functional studies are still limited to a small
proportion of the PP2C repertoire. Given its homology to
mammalian PP2C α/β isoforms, it is likely that Alph also plays
some of the roles that have been attributed to these enzymes. For
instance, growing evidence indicates that mammalian PP2C α/β
down-regulate stress-activated protein kinase (SAPK) pathways
by dephosphorylating specific core kinases of the JNK and p38
pathways (Tamura et al., 2002). This latter connection to SAPK
pathways is highly probable as genetic analysis of related PP2Cs
in S. cerevisiae and in plants indicated that this is one of their
major functions (Saito and Tatebayashi, 2004; Schweighofer et
al., 2004). In light of this putative function for Alph, it will be
interesting to determine whether its ability to affect RAS/MAPK
signaling is related to a role in SAPK signaling.
Database searches coupled to the Simple Modular Architec-
ture Research Tool (SMART; Letunic et al., 2004) identified
fifteen genes encoding phosphatases of the PPM family in
Drosophila (Supplemental Table 1). Fourteen of these corre-
spond to PP2Cs, and all except one have mammalian counter-
parts. Surprisingly, even though metazoans have several PP2C-
encoding genes (Supplemental Fig. S1), very little has been
learned genetically about their respective roles. Indeed, only the
Caenorhabditis elegans fem-2 gene, which encodes a PP2C
regulating sex determination, has thus far been characterizedotypes. Scanning electron micrographs of adult eyes of the following genotypes:
v-RASV12]/+; P[sE-alph]/+. (E) P[sev-Sem]/+. (F) P[sev-Sem]/P[sE-alph]. (G)
ult eye sections. Genotypes are as in panels E to H, respectively. Identical results
ll as with lines expressing either of the two other variants (RA/C/D and RE).
Fig. 8. Alph overexpression blocks RASV12-induced MAPK activation. (A–C) Third instar larval eye discs were stained with α-dpMAPK to detect the di-
phosphorylated (dp) active form of MAPK. Anterior is to the left. (A) alphS-331 homozygous mutant clones are marked by the absence of GFP staining. According to
the intensity of the fluorescence signal, dpMAPK levels do not appear to be significantly elevated in homozygous mutant patches (GFP-negative) compared to adjacent
heterozygous or homozygous wild-type areas. The dotted line represents the position of the morphogenetic furrow (Wolff and Ready, 1993). (B) As previously
reported (Prober and Edgar, 2002), clonal expression of RASV12 (clones are marked by GFP) leads to rounded clones appearing as cell masses which intensely stain for
active MAPK. The yellow signal is caused by merging GFP and dpMAPK (Cy3) signals. (C) Clonal expression of Alph along with RASV12 not only strongly
attenuates RASV12-activated dpMAPK levels but also prevents the clones from adopting a rounded shape (this latter phenomenon also appears to depend on MAPK
signaling (Prober and Edgar, 2002).
243C. Baril, M. Therrien / Developmental Biology 294 (2006) 232–245genetically (Chin-Sang and Spence, 1996). Our work therefore
represents only the second genetic study of a PP2C gene in a
metazoan. The availability of additional transposon-disrupted
PP2C loci (Supplemental Table 2) as well as RNAi-based
approaches should now accelerate the characterization of this
class of phosphatases in metazoans.
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